
    
      After an initial screening period of up to 4 weeks, eligible subjects were randomised (1:1:2)
      to 1 of the following 3 treatment arms for a period of 52 weeks.

        1. FCM regimen (maximum single intravenous doses of 1,000 mg of iron) targeting a ferritin
           level of 400-600 mcg/L.

        2. FCM regimen (maximum single intravenous doses of 200 mg of iron) targeting a ferritin
           level of 100-200 mcg/L.

        3. Daily oral iron with 200 mg iron/day (100 mg twice daily)
    
  